Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Olesoxime (TRO19622) is a novel mitochondrial-targeted neuroprotective compound undergoing a pivotal clinical efficacy study in Amyotrophic Lateral Sclerosis (ALS) and also in development for Spinal Muscular Atrophy (SMA).It belongs to a new family of cholesterol-oximes identified for its survival-promoting activity lively bras return policy on pur